Introduction: Ibuprofen is emerging as a reasonable alternative to indomethacin for closing patent ductus arteriosus (PDA) in preterm infants with respiratory distress syndrome (RDS) (Arch Dis Child 97;76:F179). Moreover it has been shown that it does not reduce cerebral blood flow and causes less impairment of intestinal hemodynamics.
Objective: To evaluate efficiency and side effects of ibuprofen as compared to indomethacin for early treatment of PDA in preterm infants with RDS.
Design and Setting: Randomized prospective multicenter trial at tertiary level NICU's.
Patients and Methods: 103 preterm infants with RDS, after rescue treatment with exogenous surfactant, on artificial ventilation, with echocardiographically proven PDA on day 3 of life, were randomized to either indomethacin i.v. (INDO) 3× 0.2 mg / kg at 12 hr intervals (birth weight(BW): 1240 ± 370 g; gestational age (GA): 29.1 ± 2.0 wks; mean± ISD) or ibuprofen-lysine i.v. treatment (IBU) 10-5-5 mg / kg at 24 hr intervals (BW: 1290 ± 400 g; GA: 29.3 ± 2.3 wks). Ductal closure, backup treatment or ligation, renal-, intestinal-, central-, hematologic and respiratory evolution were registered.
Results: PDA was closed in 37/51 (73%) in the INDO vs 39/52 (75%) in the IBU group on day 7 of life. Backup treatment and/or ligation was necessary in 7 and 5 in INDO vs 9 and 5 in IBU patients. There were no significant differences in days of ventilation (12± 9 vs 13 ± 14), days on supplemental oxygen (28± 25 vs 30 ± 33), number of deaths (4 vs 5), days to regain BW (20 ± 2 vs 21 ± 2), days to full enteral feeding (28 ± 15 vs 29 ± 14), number of intraventricular hemorrhages all grades (7 vs 7) for INDO vs IBU groups respectively. There was a trend to lower urine production (days 3-5) and higher serum creatinine values (days 5-8) in the INDO group.
Conclusion: Early ibuprofen treatment for PDA in preterm infants with RDS on day 3 of life is as efficient and without increased adverse effects, as compared to indomethacin.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Overmeire, B., Langhendries, J., Vanhaesebrouck, P. et al. Ibuprofen for Early Treatment of Patent Ductus Arteriosus, a Randomized Multicenter Trial. • 1167. Pediatr Res 43 (Suppl 4), 200 (1998). https://doi.org/10.1203/00006450-199804001-01188
Issue Date:
DOI: https://doi.org/10.1203/00006450-199804001-01188